机构名称：
¥ 1.0
Chairs: Erol Tülümen, Sven Reischauer 4x15 min talks, 15 min QA 3.1 Peter Ferdinandy (Budapest, Hungary) Discovery and development of miRNA therapeutics for cardioprotection and other indications 3.2 Ender Ödemiş (Istanbul, Turkey) Three dimensional modelling and simulations in the treatment of congenital heart disease 3.3 Coert J Zuurbier (Amsterdam, The Netherlands) Malonate at reperfusion increases RISK pathway and 4-HNE in hearts with high glucose metabolism and associates with loss of cardioprotection against ischemia-reperfusion injury 3.4 Kemal Baysal (Istanbul, Turkey) An in vitro co-culture model to study exosomes in vascular cell communication Coffee break 15:45 – 16:15 Chairs: Peter Ferdinandy, Dilek Ural 4x15 min talks, 15 min QA 3.5 Hector A. Cabrera-Fuentes (Oaxaca, Mexico) Mitochondrial fission regulator Drp-1 as a novel therapeutic target to prevent atherosclerosis 3.6 Thomas Krieg (Cambridge, UK) Clinical development of acidic malonate in ischemia-reperfusion Injury 3.7 MüjdatZeybel（土耳其伊斯坦布尔）跨病因的慢性肝病中晚期纤维化的整合蛋白转录表征3.8 Indrajit Banerjee（SSR，Mauritius，Mauritius，Mauritius）由于COVID-19疫苗而引起的心脏并发症
伊斯坦布尔，土耳其9月26日至2024年27日
主要关键词
相关文件推荐
